Lipocine Inc. Annual Income Tax Expense (Benefit) in USD from 2012 to 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Lipocine Inc. annual/quarterly Income Tax Expense (Benefit) history and growth rate from 2012 to 2024.
- Lipocine Inc. Income Tax Expense (Benefit) for the quarter ending June 30, 2024 was $481.000.
- Lipocine Inc. annual Income Tax Expense (Benefit) for 2024 was $681.000, a 9.8% decline from 2023.
- Lipocine Inc. annual Income Tax Expense (Benefit) for 2023 was $755.000, a 10.9% increase from 2022.
- Lipocine Inc. annual Income Tax Expense (Benefit) for 2022 was $681.000, a 241% increase from 2021.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)